Neuropace Inc share price logo

Neuropace Inc Share Price

NASDAQ: NPCE

Small Cap

$17.30

+0.32

(+1.88%)

Live

as on

Neuropace Inc Stock Performance

as on April 24, 2026 at 1:07 am IST

  • Day's Low

    Day's High

    $16.80
    $17.28
    downward going graph

    2.89%

    Downside

    -0.12%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $7.56
    $18.98
    downward going graph

    56.29%

    Downside

    9.68%

    Upside

    downward going graph

Neuropace Inc share price movements today

Previous Close
$16.98
Open
$16.80
Volume
25.7K
Day's Low - High
$16.80 - $17.28
52 Week Low - High
$7.56 - $18.98

Neuropace Inc Historical Returns

1 Month Return
+ 26.91 %
3 Month Return
+ 1.62 %
1 Year Return
+ 55.64 %
3 Year Return
+ 299.53 %
5 Year Return
-33.25 %

Neuropace Inc Stock Fundamentals & Key Indicators

Check Neuropace Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$551.1M

EPS (TTM)

-0.5978

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-16.1M

Revenue (TTM)

100.0M

Profit Margin

-21.47%

Return On Equity TTM

-158.74%

Neuropace Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Neuropace Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Neuropace Inc image
Neuropace Inc
BUY$551.1M-33.25%NA-21.47%
Boston Scientific Corp image
Boston Scientific Corp
BUY$96.4B51.81%27.1414.44%
Stryker Corporation image
Stryker Corporation
BUY$125.4B23.35%40.3112.92%
Medtronic PLC image
Medtronic PLC
BUY$106.8B-36.57%23.2513.00%
Edwards Lifesciences Corp image
Edwards Lifesciences Corp
BUY$47.4B-16.34%45.0417.69%
See all

Stock Returns calculator for Neuropace Inc Stock including INR - Dollar returns

The Neuropace Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Neuropace Inc investment value today

Current value as on today

₹1,75,148

Returns

₹75,148

(+75.15%)

Returns from Neuropace Inc Stock

₹58,570 (+58.57%)

Dollar Impact

₹16,577 (+16.58%)

Analyst Recommendation on Neuropace Inc Stock

Based on 13 analysts

BUY

84.62%

Buy

15.38%

Hold

0.00%

Sell

Based on 13 analysts, 84.62% of analysts recommend a 'BUY' rating for Neuropace Inc. Average target price of $19.88

Neuropace Inc Share Price Target

Get share price movements and forecasts by analysts on Neuropace Inc.

What analysts predicted

12.98%UPSIDE

Target Price

$19.88

Current Price

$17.3

Analyzed by

13 Analysts

Target

$19.88

Neuropace Inc target price $19.88, a slight upside of 12.98% compared to current price of $17.3. According to 13 analysts rating.

Neuropace Inc Stock’s Investor Sentiment and Interest

Search interest for Neuropace Inc Stock has decreased by -61% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-61% versus previous 30 day period

Neuropace Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
16
18
18
19
21
21
22
23
27
26
Gross Profit
12
13
13
14
15
16
17
18
21
20
Operating Income
-5
-5
-7
-6
-4
-3
-5
-6
-2
-1
EBITDA
-4
-3
-6
-4
-2
-2
-3
-6
-2
-1
Interest Expense
2
2
2
2
2
2
2
2
0
1
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-7
-6
-8
-7
-5
-5
-6
-8
-3
-2
Income Tax Expense
2
-8
0
-
-
0
-
-
-
-8
Net Income
-7
-6
-8
-7
-5
-5
-6
-8
-3
-2
Net Profit Margin
-44.18%
-34.42%
-49.24%
-39.02%
-25.89%
-24.46%
-29.25%
-36.78%
-12.78%
-10.26%

Neuropace Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
36
41
45
45
65
79
99
Gross Profit
26
30
33
32
48
59
77
Operating Income
-22
-13
-23
-40
-27
-21
-16
EBITDA
-20
-12
-28
-36
-22
-16
-14
Interest Expense
9
11
7
7
8
8
7
Depreciation
0
0
0
2
1
1
1
Income Before Tax
-29
-24
-36
-47
-32
-27
-21
Income Tax Expense
10
11
2
6
1
-
-
Net Income
-29
-24
-36
-47
-32
-27
-21
Net Profit Margin
-81.07%
-59.02%
-79.85%
-103.43%
-50.38%
-33.97%
-21.47%

Neuropace Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-6
-8
-7
-5
-5
-6
-8
-3
-2
Operating Cash Flow
-3
-7
-3
-1
-4
-7
-2
-1
0
Investing Cash Flow
3
2
3
1
1
0
0
0
0
Financing Cash Flow
8
0
0
2
0
21
-1
0
0
Change in Cash
8
-5
0
2
-1
13
-4
-2
1

Neuropace Inc Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-24
-36
-47
-32
-27
-21
Operating Cash Flow
-21
-24
-36
-19
-17
-11
Investing Cash Flow
-10
-85
23
23
8
0
Financing Cash Flow
55
102
0
8
4
19
Change in Cash
22
-7
-12
11
-4
8

Global Institutional Holdings in Neuropace Inc

Funds
Holdings
Deutsche Bank AG
2.76%
Walleye Trading Advisors, LLC
0.68%
Orbimed Advisors, LLC
7.76%
Polar Capital Holdings PLC
8.55%
Vanguard Group Inc
4.4%
See all

Insights on Neuropace Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, NPCE stock has moved up by 9.7%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, NPCE has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, NPCE has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -8.65M → -2.72M (in $), with an average increase of 87.8% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 27.35M → 26.58M (in $), with an average decrease of 2.8% per quarter

About Neuropace Inc

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
OrganisationNeuropace Inc
Headquarters455 North Bernardo Avenue, Mountain View, CA, United States, 94043
IndustryMedical Devices
CEOMr. Joel D. Becker
E-voting on sharesClick here to vote

Key Management of Neuropace Inc

Name

Title

Mr. Joel D. Becker

CEO, President & Director

Dr. Martha J. Morrell M.D.

Chief Medical Officer

Ms. Rebecca L. Kuhn

Advisor

Mr. Patrick F. Williams

Chief Financial Officer

Mr. Dylan St. John

Chief of Operations & Development

Mr. Scott R. Schaper

Head of Investor Relations

Ms. Katie Keller

Vice President of Marketing

Ms. Leah Akin

General Counsel & Corporate Secretary

Mr. Chris Reese

Senior Vice President of Sales

Ms. Amy Treadwell

Vice President of Human Resources

FAQs

What is Neuropace Inc share price today?

Neuropace Inc share price today is $17.3 as on . Neuropace Inc share today touched a day high of $17.28 and a low of $16.8.

What is the 52 week high and 52 week low for Neuropace Inc share?

Neuropace Inc share touched a 52 week high of $18.98 on and a 52 week low of $7.56 on . Neuropace Inc stock price today i.e. is trending at $17.3,which is 8.83% down from its 52 week high and 128.76% up from its 52 week low.

What is Neuropace Inc's market capitalisation today?

Neuropace Inc market capitalisation is $0.00T as on .

How to invest in Neuropace Inc Stock (NPCE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Neuropace Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Neuropace Inc Shares that will get you 0.0867 shares as per Neuropace Inc share price of $17.3 per share as on April 23, 2026 at 7:37 pm IST.

What is the minimum amount required to buy Neuropace Inc Stock (NPCE) from India?

Indian investors can start investing in Neuropace Inc (NPCE) shares with as little as ₹94.085 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹940.85 in Neuropace Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Neuropace Inc share’s latest price of $17.3 as on April 23, 2026 at 7:37 pm IST, you will get 0.5780 shares of Neuropace Inc. Learn more about fractional shares .

What are the returns that Neuropace Inc has given to Indian investors in the last 5 years?

Neuropace Inc stock has given -33.25% share price returns and 23.96% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?